Guardant Health Launched Shield Blood-based Screening Test For Colorectal Cancer In S. Korea
Guardant Health Launched Shield Blood-based Screening Test For Colorectal Cancer In S. Korea
Guardant Health 在韓國推出基於盾牌血液的結直腸癌篩查測試
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
領先的精準腫瘤學公司Guardant Health, Inc.（納斯達克股票代碼：GH）宣佈，它已與韓國三星醫療中心合作推出血液基結直腸癌篩查測試ShieldTM。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。